SEMLER SCIENTIFIC INC (SMLR) Stock Fundamental Analysis
USA - NASDAQ:SMLR - US81684M1045 - Common Stock
28.2 USD
-0.16 (-0.56%)
28.29 USD
+0.09 (+0.32%)
SMLR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. While SMLR belongs to the best of the industry regarding profitability, there are concerns on its financial health. SMLR has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year SMLR was profitable.
SMLR had a positive operating cash flow in the past year.
SMLR had positive earnings in each of the past 5 years.
SMLR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 7.09%, SMLR belongs to the best of the industry, outperforming 89.01% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.66%, SMLR belongs to the top of the industry, outperforming 84.82% of the companies in the same industry.
SMLR has a Return On Invested Capital of 0.92%. This is in the better half of the industry: SMLR outperforms 68.06% of its industry peers.
SMLR had an Average Return On Invested Capital over the past 3 years of 20.14%. This is significantly above the industry average of 9.00%.
The last Return On Invested Capital (0.92%) for SMLR is well below the 3 year average (20.14%), which needs to be investigated, but indicates that SMLR had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.09% | ||
| ROE | 9.66% | ||
| ROIC | 0.92% |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
1.3 Margins
SMLR's Profit Margin of 86.20% is amongst the best of the industry. SMLR outperforms 98.95% of its industry peers.
In the last couple of years the Profit Margin of SMLR has grown nicely.
Looking at the Operating Margin, with a value of 12.16%, SMLR is in the better half of the industry, outperforming 79.58% of the companies in the same industry.
In the last couple of years the Operating Margin of SMLR has grown nicely.
SMLR has a Gross Margin of 90.91%. This is amongst the best in the industry. SMLR outperforms 98.43% of its industry peers.
In the last couple of years the Gross Margin of SMLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.16% | ||
| PM (TTM) | 86.2% | ||
| GM | 90.91% |
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
SMLR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for SMLR has been increased compared to 1 year ago.
SMLR has more shares outstanding than it did 5 years ago.
SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 2.22 indicates that SMLR is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of SMLR (2.22) is better than 62.83% of its industry peers.
The Debt to FCF ratio of SMLR is 7.90, which is on the high side as it means it would take SMLR, 7.90 years of fcf income to pay off all of its debts.
SMLR has a better Debt to FCF ratio (7.90) than 75.39% of its industry peers.
SMLR has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of SMLR (0.25) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 7.9 | ||
| Altman-Z | 2.22 |
ROIC/WACC0.1
WACC8.78%
2.3 Liquidity
SMLR has a Current Ratio of 0.60. This is a bad value and indicates that SMLR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.60, SMLR is doing worse than 92.15% of the companies in the same industry.
A Quick Ratio of 0.58 indicates that SMLR may have some problems paying its short term obligations.
The Quick ratio of SMLR (0.58) is worse than 91.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.58 |
3. Growth
3.1 Past
SMLR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 201.43%, which is quite impressive.
SMLR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.17% yearly.
The Revenue for SMLR has decreased by -30.40% in the past year. This is quite bad
The Revenue has been growing by 11.43% on average over the past years. This is quite good.
EPS 1Y (TTM)201.43%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%687.5%
Revenue 1Y (TTM)-30.4%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-43.19%
3.2 Future
Based on estimates for the next years, SMLR will show a very negative growth in Earnings Per Share. The EPS will decrease by -29.01% on average per year.
SMLR is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -16.29% yearly.
EPS Next Y-123.34%
EPS Next 2Y-42.88%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue Next Year-43.54%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 3.35, the valuation of SMLR can be described as very cheap.
Based on the Price/Earnings ratio, SMLR is valued cheaply inside the industry as 97.91% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.91, SMLR is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for SMLR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.35 | ||
| Fwd PE | N/A |
4.2 Price Multiples
63.87% of the companies in the same industry are more expensive than SMLR, based on the Enterprise Value to EBITDA ratio.
79.06% of the companies in the same industry are more expensive than SMLR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.57 | ||
| EV/EBITDA | 90.58 |
4.3 Compensation for Growth
SMLR has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as SMLR's earnings are expected to decrease with -29.01% in the coming years.
PEG (NY)N/A
PEG (5Y)0.14
EPS Next 2Y-42.88%
EPS Next 3Y-29.01%
5. Dividend
5.1 Amount
SMLR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
28.2
-0.16 (-0.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners71.06%
Inst Owner Change0%
Ins Owners4.93%
Ins Owner Change0.32%
Market Cap433.15M
Analysts82.22
Price Target76.84 (172.48%)
Short Float %19.88%
Short Ratio2.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-23.13%
PT rev (3m)6.1%
EPS NQ rev (1m)150%
EPS NQ rev (3m)N/A
EPS NY rev (1m)62.37%
EPS NY rev (3m)-172.16%
Revenue NQ rev (1m)-3.28%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.33%
Revenue NY rev (3m)-44.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.35 | ||
| Fwd PE | N/A | ||
| P/S | 10.08 | ||
| P/FCF | 35.57 | ||
| P/OCF | 34.76 | ||
| P/B | 1.13 | ||
| P/tB | N/A | ||
| EV/EBITDA | 90.58 |
EPS(TTM)8.41
EY29.82%
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)0.79
FCFY2.81%
OCF(TTM)0.81
OCFY2.88%
SpS2.8
BVpS24.96
TBVpS-7.39
PEG (NY)N/A
PEG (5Y)0.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.09% | ||
| ROE | 9.66% | ||
| ROCE | 1.08% | ||
| ROIC | 0.92% | ||
| ROICexc | 0.95% | ||
| ROICexgc | N/A | ||
| OM | 12.16% | ||
| PM (TTM) | 86.2% | ||
| GM | 90.91% | ||
| FCFM | 28.34% |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
ROICexc(3y)84.34%
ROICexc(5y)123.7%
ROICexgc(3y)231.99%
ROICexgc(5y)212.29%
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexcg growth 3Y32.01%
ROICexcg growth 5Y21.37%
ROICexc growth 3Y-65.32%
ROICexc growth 5Y-45.58%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score3
Asset Turnover0.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 7.9 | ||
| Debt/EBITDA | 16.92 | ||
| Cap/Depr | 60.82% | ||
| Cap/Sales | 0.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 218.98% | ||
| Profit Quality | 32.88% | ||
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.58 | ||
| Altman-Z | 2.22 |
F-Score3
WACC8.78%
ROIC/WACC0.1
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)201.43%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%687.5%
EPS Next Y-123.34%
EPS Next 2Y-42.88%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.4%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-43.19%
Revenue Next Year-43.54%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
EBIT growth 1Y-75.28%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year-342.47%
EBIT Next 3Y-51.48%
EBIT Next 5YN/A
FCF growth 1Y-37.74%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y-42.82%
OCF growth 3Y14.98%
OCF growth 5Y13.91%